Women’s Health Market Size, Share & Trends Report

Women’s Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives), By Age, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-634-9
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Women’s Health Market Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Endometriosis & Uterine Fibroids
- Contraceptives
- Menopause
- Polycystic Ovary Syndrome (PCOS)
Women’s Health Market Age Outlook (Revenue, USD Billion, 2018 - 2030)
- 50 years and above
  - Postmenopausal Osteoporosis
  - Endometriosis & Uterine Fibroids
  - Menopause
  - Others
- Others
Women’s Health Market Regional Outlook (Revenue, USD Billion; 2018 - 2030)
- North America
  - North America Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - North America Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - U.S. Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - U.S. Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Canada Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Canada Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
- Europe
  - Europe Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Europe Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - UK Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - UK Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - 法国女性健康的市场,由应用程序(梦nue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - France Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Italy Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Italy Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Spain Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Spain Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Denmark Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Denmark Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - 瑞典女性健康的市场,由应用程序(梦nue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Sweden Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Norway Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Norway Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
- Asia Pacific
  - Asia Pacific Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Asia Pacific Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - China Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - China Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Japan Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Japan Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - India Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - India Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Australia Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Australia Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - South Korea Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - South Korea Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Thailand Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Thailand Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
- Latin America
  - Latin America Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Latin America Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Brazil Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Brazil Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Mexico Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Mexico Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Argentina Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Argentina Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
- Middle East & Africa
  - Middle East & Africa Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Middle East & Africa Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - South Africa Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - South Africa Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Saudi Arabia Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Saudi Arabia Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - UAE Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - UAE Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Kuwait Women’s Health Market, By Application (Revenue, USD Billion, 2018 - 2030)
    - Postmenopausal Osteoporosis
    - Hormonal Infertility
    - Endometriosis & Uterine Fibroids
    - Contraceptives
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Kuwait Women’s Health Market, By Age (Revenue, USD Billion, 2018 - 2030)
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.